Credentials & Testimonials
“I was impressed by the remarkable efficacy, rapidity and smoothness of the service provided by FairJourney Biologics: 14 days between the hybridoma cells leaving our lab, and reception of the variable domain sequences! With scientists at FairJourney always readily answering all questions we had about the project. Very fruitful experience!”
” Since initiating our first milestone-based therapeutic antibody partnership in October 2012, IONTAS have successfully completed multiple antibody discovery projects with companies based in the USA, Europe, Australia and Far East. IONTAS have also granted licenses to our antibody phage display library technology which has underpinned this success. For example, we granted a license for an antibody phage display library to Agenus, an immunology company engaged in the discovery and development of novel checkpoint modulators, vaccines and adjuvants to treat cancer and other diseases. ”
“FairJourney Biologics has demonstrated the capacity to deliver high quality antibody engineering services. The team is very experienced in phage display for the discovery of antibodies from rodent immune repertoires for diagnostic and therapeutic applications. Humanization is performed by affinity driven selections of libraries to avoid loss in potency. Desired specificity and optimal affinities can be achieved by applying appropriate selection methods thereby delivering leads useful for the development of highly specific and sensitive diagnostic assays. The outstanding track record of its research team, has enable the company to provide us with new antibodies with excellent characteristics.”
“I had the opportunity to work with FairJourney Biologics since last year and I am impressed by the skills and speed the different projects are delivered. I was personally involved in a project in summer 2013 in which we pulled out together 121 leads of highly specific antibodies in just 3 days. Moreover, the whole teams respires such a enthusiasm that it is a pleasure to work with FairJourney Biologics and I can recommend them to anyone looking for desired new antibodies.”
We have been granted approval for French Partners to receive tax credit based on our current research capabilities.